EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Low and High Pressor Doses of Ang II Lead to Two Distinct Phenotypes of Hypertensive Heart Disease in Mice

Diana Törmä iD, Tuisku Suoranta, Mimmi Rinta-Harri, Jarkko Hytönen iD, Seppo Ylä-Herttuala, Anna-Kaisa Ruotsalainen iD

APMIS · 2026-01 · 134 (1)

DOI: 10.1111/apm.70132 ↗

Kurz gefasst

Fachartikel in der Zeitschrift APMIS, online erschienen am 06.01.2026. Verfasst von Diana Törmä und 5 weiteren Autor:innen. Beteiligte Einrichtung: A.I. Virtanen Institute, University of Eastern Finland, Kuopio, Finland. Hauptthemen laut MEDLINE: Angiotensin II, Hypertension. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Council of Finland GeneCellNano Flagship Program, Sydäntutkimussäätiö, Research Council of Finland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypertension is a major contributor to cardiovascular diseases, being the most common comorbidity and the biggest risk factor in heart failure with preserved ejection fraction. Angiotensin II (Ang II) is a known hypertension and heart failure inducer in mice, but its role in the causality in phenotype development remains unclear. Here, hypertension was induced with low (LowA) or high (HighA) pressor doses of Ang II in mice. Both LowA and HighA groups demonstrated equal levels of hypertension with aortic dilatation and decreased aortic wall strain, but only HighA developed left ventricular hypertrophy with advanced cardiac dysfunction, demonstrating the hypertension‐independent effects of Ang II on myocardial remodeling. Alterations in electrical conductivity occurred similarly in both groups, with prominent ECG waveform aberrations. The study demonstrates two distinct hypertensive heart disease phenotypes induced by Ang II, providing a valuable preclinical framework that emphasizes the critical role of Ang II in diastolic dysfunction and vascular remodeling beyond its effects on the regulation of blood pressure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angiotensin IIHypertensionAnimalsMicePhenotypeMaleMice, Inbred C57BLDisease Models, AnimalBlood PressureHypertrophy, Left VentricularAortaElectrocardiographyVentricular Remodeling

Stichwörter der Autor:innen

diastolic dysfunctionheart failurehypertensionremodeling

Substanzen

Angiotensin II

Autor:innen und Institutionen

  • A.I. Virtanen Institute, University of Eastern Finland, Kuopio, Finland.
  • Heart Center and Gene Therapy Unit, Kuopio University Hospital, Kuopio, Finland.

ORCID-Profile: Diana Törmä, Jarkko Hytönen, Anna-Kaisa Ruotsalainen

Förderung

  • Research Council of Finland GeneCellNano Flagship Program
  • Sydäntutkimussäätiö
  • Research Council of Finland
  • Emil Aaltosen Säätiö
  • Orionin Tutkimussäätiö
  • Aarne Koskelon Säätiö
  • Päivikki ja Sakari Sohlbergin Säätiö
  • Aarne ja Aili Turusen Säätiö

Zitieren

APA

Törmä, D., Suoranta, T., Rinta-Harri, M., Hytönen, J., Ylä-Herttuala, S., & Ruotsalainen, A. K. (2026). Low and High Pressor Doses of Ang II Lead to Two Distinct Phenotypes of Hypertensive Heart Disease in Mice. APMIS, 134(1). https://doi.org/10.1111/apm.70132

Vancouver

Törmä D, Suoranta T, Rinta-Harri M, Hytönen J, Ylä-Herttuala S, Ruotsalainen AK. Low and High Pressor Doses of Ang II Lead to Two Distinct Phenotypes of Hypertensive Heart Disease in Mice. APMIS. 2026;134(1). doi:10.1111/apm.70132

BibTeX
@article{Trm2026,
  author = {Törmä, Diana and Suoranta, Tuisku and Rinta-Harri, Mimmi and Hytönen, Jarkko and Ylä-Herttuala, Seppo and Ruotsalainen, Anna-Kaisa},
  title = {Low and High Pressor Doses of Ang II Lead to Two Distinct Phenotypes of Hypertensive Heart Disease in Mice},
  journal = {APMIS},
  year = {2026},
  volume = {134},
  number = {1},
  doi = {10.1111/apm.70132}
}
Kostenlos starten →